NCT05822674View on ClinicalTrials.gov

Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

February 1, 2023

Conditions
Type 2 Diabetes
Interventions
DRUG

Sitagliptin/metformin ( 50/500mg) Oral Tablet

The drug was prescribed once daily per oral for 10 weeks

DRUG

Empagliflozin/metformin(10/500mg) Oral Tablet

The drug was prescribed once daily per oral for 10 weeks

Trial Locations (1)

32001

College of Medicine, University of Diyala, Baqubah

All Listed Sponsors
lead

University of Diyala

OTHER

NCT05822674 - Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio | Biotech Hunter | Biotech Hunter